Note 15 - Shareholders' Equity |
12 Months Ended | ||
|---|---|---|---|
Jun. 30, 2025 | |||
| Notes to Financial Statements | |||
| Equity [Text Block] |
Shares Authorized for Issuance
Our authorized capital stock consists of 150,000,000 shares of common stock, par value $0.01 per share, and 1,055,000 shares of Preferred Stock, par value $0.01 per share. The Board of Directors may provide for the issuance of all or any shares of Preferred Stock in one or more classes or series, and to fix for each such class or series such voting powers, full or limited, or no voting powers, and such distinctive designations, preferences and relative, participating, optional or other special rights and such qualifications, limitations or restrictions thereof, as shall be stated and expressed in the resolution or resolutions adopted by the Board of Directors providing for the issuance of such class or series and as may be permitted by the General Corporation Law of the State of Delaware. At June 30, 2025 and 2024, there were shares of Preferred Stock issued or outstanding.
Share Repurchase Program
There were no share repurchases under the Company’s existing multi-year share repurchase program during fiscal 2025, 2024 or 2023. At June 30, 2025, we had a remaining Board authorization to repurchase 2,007,364 shares of our common stock pursuant to our share repurchase program. There is no expiration date on the repurchase authorization. The timing and amount of any future share repurchases in the open market and through privately negotiated transactions will be determined by the Company’s officers at their discretion and based on a number of factors, including an evaluation of market and economic conditions while also maintaining financial flexibility.
Dividends
We paid four regular quarterly cash dividends and a special cash dividend during fiscal 2025. Total cash dividends paid to shareholders in fiscal 2025 were $1.96 per share and totaled $50.1 million. During fiscal 2024, total cash dividends paid were $50.3 million. |